Daniel Vitt

Insider Reports History

Reporting-owner location: Martinsried, Germany
Latest reporting-owner signature: /s/ Daniel Vitt
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Daniel Vitt

Form 4 holding CEO and Director, Director

IMMUNIC, INC.

Security class: Common Stock
Shares / value: 362,877
Estimated value: $330,218
Report date: 04 Jun 2025
Price: $0.9100
Ownership: Indirect

Form 4 holding CEO and Director, Director

IMMUNIC, INC.

Security class: Common Stock
Shares / value: 29,000
Estimated value: $22,330
Report date: 04 Jun 2025
Price: $0.7700
Ownership: Direct

Form 4 holding CEO and Director, Director

IMMUNIC, INC.

Security class: Stock Option
Shares / value: 1,558,000
Estimated value
Report date: 05 Jun 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding CEO and Director, Director

IMMUNIC, INC.

Security class: Stock Appreciation Right
Shares / value: 860,000
Estimated value
Report date: 16 Jul 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Daniel Vitt

4 IMUX

IMMUNIC, INC.

Report period: 16 Jul 2025
Transactions: 5
Transaction value: $0
Accepted by SEC: 18 Jul 2025, 16:05
Role: CEO and Director, Director
Next action: Open filing details

4/A IMUX

IMMUNIC, INC.

Report period: 04 Jun 2025
Transactions: 2
Transaction value: +$11,550
Accepted by SEC: 20 Jun 2025, 17:15
Role: CEO and Director, Director
Next action: Open filing details

4 IMUX

IMMUNIC, INC.

Report period: 04 Dec 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Dec 2024, 17:30
Role: CEO and Director, Director
Next action: Open filing details

4 IMUX

IMMUNIC, INC.

Report period: 04 Mar 2024
Transactions: 6
Transaction value: $0
Accepted by SEC: 06 Mar 2024, 21:51
Role: President and CEO, Director
Next action: Open filing details

4 IMUX

IMMUNIC, INC.

Report period: 26 Feb 2024
Transactions: 1
Transaction value: +$18,333
Accepted by SEC: 28 Feb 2024, 17:19
Role: President and CEO, Director
Next action: Open filing details

4 IMUX

IMMUNIC, INC.

Report period: 17 Jan 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 19 Jan 2024, 16:07
Role: Chief Executive Officer, Director
Next action: Open filing details

4 IMUX

IMMUNIC, INC.

Report period: 02 Jan 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Jan 2023, 20:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 IMUX

IMMUNIC, INC.

Report period: 22 Nov 2022
Transactions: 1
Transaction value: +$10,799
Accepted by SEC: 23 Nov 2022, 09:13
Role: President and CEO, Director
Next action: Open filing details

4 IMUX

IMMUNIC, INC.

Report period: 15 Jun 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Jun 2022, 21:32
Role: President and CEO, Director
Next action: Open filing details

4 IMUX

IMMUNIC, INC.

Report period: 03 Jun 2022
Transactions: 1
Transaction value: +$15,500
Accepted by SEC: 06 Jun 2022, 08:31
Role: President and CEO, Director
Next action: Open filing details

4 IMUX

IMMUNIC, INC.

Report period: 03 Jan 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Jan 2022, 15:02
Role: Chief Executive Officer, Director
Next action: Open filing details

4 IMUX

IMMUNIC, INC.

Report period: 10 Aug 2021
Transactions: 1
Transaction value: +$9,600
Accepted by SEC: 11 Aug 2021, 09:04
Role: President and CEO, Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .